REG - Tristel PLC - Notice of Preliminary Results

TristelAnnouncement

01/10/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241001:nRSA3129Ga&default-theme=true

RNS Number : 3129G  Tristel PLC  01 October 2024

TRISTEL plc

("Tristel" or the "Company")

 

Notice of Preliminary Results

Investor presentations

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that its preliminary results for the year ended 30 June 2024 will be
announced on Monday 21 October 2024.

 

Analyst briefing

A briefing open to analysts will take place in London on Monday 21 October
2024 at 10:00 BST. To register and for more details please contact Walbrook PR
on tristel@walbrookpr.com (mailto:tristel@walbrookpr.com)

 

Investor presentations

Matt Sassone, CEO, and Liz Dixon, CFO, will present the Company's results in
two separate events open to all investors. The same presentation will be given
at both events which are being held at different times to offer convenient
options for those wishing to attend.

 

Two presentations will take place on Monday 21 October 2024 at the following
times, the first will be held online via the Investor Meet Company platform
and the second will be held in-person in the City of London, full details
below:

 

1.    Investor Meet Company online presentation

Tristel management will provide a live online presentation relating to
the preliminary results via Investor Meet Company at 11:30 BST. The
presentation is open to all existing and potential shareholders. Questions can
be submitted pre-event via your Investor Meet Company dashboard up until 09:00
BST the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to
meet Tristel plc via:

https://www.investormeetcompany.com/tristel-plc/register-investor
(https://www.investormeetcompany.com/tristel-plc/register-investor)

 

2.    In-person investor presentation

Tristel management will provide an in-person presentation relating to the
Company's preliminary results at 16:30 BST, which is open to all existing and
potential shareholders. The Company welcomes investors to 85 Gresham Street,
London, EC2V 7NQ from 16:15 BST for a 16:30 BST start and will be followed by
refreshments.

 

If you would like to attend, please contact Walbrook PR on 020 7933 8780 or
email tristel@walbrookpr.com.

 

The results presentation will be made available on the Company's website on
the day of results www.investors.tristel.com
(http://www.investors.tristel.com/)

 

For further information please contact:

 

 Tristel plc                                                        Via Walbrook PR
 Matt Sassone, Chief Executive Officer                              www.investors.tristel.com (http://www.investors.tristel.com/)
 Liz Dixon, Chief Financial Officer

 Walbrook PR Ltd                                                    Tel: 02079338780 or tristel@walbrookpr.com
 Paul McManus / Alice Woodings                                      Mob: 07980 541 893 / 07407 804 654

 Cavendish Capital Markets Ltd                                      Tel: 020 7220 0500
 Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (ECM) / Louise Talbot (Sales)

 

About Tristel plc

 

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 250 people across 14
subsidiaries selling into 40 countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% (targets to
be updated in February 2024) and the business is profitable, with no debt and
has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORLMMATMTIJBJI